Michael G. Douvas
Impact in
-
- Acute Myeloid Leukemia Research
-
- Ear and Head Tumors
- CAR-T cell therapy research
Papers in
-
- Protein Degradation and Inhibitors 2
- Fibroblast Growth Factor Research 2
-
- Acute Myeloid Leukemia Research 4
- Co-authors
- Nikole Varhegyi (2 shared papers)Snjezana Zaja‐Milatovic (2 shared papers)Gina R. Petroni (2 shared papers)Paula M. Fracasso (2 shared papers)Patrick M. Dillon (2 shared papers)Christopher Y. Thomas (2 shared papers)Christopher A. Moskaluk (1 shared paper)Bethany J. Horton (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Blood (3 papers)Current Hematologic Malignancy Reports (2 papers)Clinical Cancer Research (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Michael G. Douvas
17 papers receiving 266 citations
Peers
Comparison fields: 5 of 45
- Hematology 42
- Oncology 69
- Pathology and Forensic Medicine 38
- Neurology 27
- Genetics 19
Countries citing papers authored by Michael G. Douvas
This map shows the geographic impact of Michael G. Douvas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Douvas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Douvas more than expected).
Fields of papers citing papers by Michael G. Douvas
This network shows the impact of papers produced by Michael G. Douvas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Douvas. The network helps show where Michael G. Douvas may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael G. Douvas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 86 | |
| 2 | 2017 | 67 | |
| 3 | 2008 | 32 | |
| 4 | 2020 | 23 | |
| 5 | 2006 | 18 | |
| 6 | 2019 | 9 | |
| 7 | 2018 | 6 | |
| 8 | 2015 | 6 | |
| 9 | 2010 | 6 | |
| 10 | 2018 | 5 | |
| 11 | 2004 | 4 | |
| 12 | 2015 | 4 | |
| 13 | 2022 | 3 | |
| 14 | 2007 | 1 | |
| 15 | 2021 | 1 | |
| 16 | 2015 | 1 | |
| 17 | 2015 | 1 | |
| 18 | 2007 | 0 | |
| 19 | 2024 | 0 | |
| 20 | 2024 | 0 |
About Michael G. Douvas
Michael G. Douvas is a scholar working on Molecular Biology, Hematology, Oncology, Public Health, Environmental and Occupational Health and Surgery, having authored 20 papers that have together received 273 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Protein Degradation and Inhibitors (2 papers), Cancer Treatment and Pharmacology (2 papers), Fibroblast Growth Factor Research (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Salivary Gland Tumors Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (42 citations), Oncology (69 citations), Pathology and Forensic Medicine (38 citations), Neurology (27 citations) and Genetics (19 citations). Michael G. Douvas has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Nikole Varhegyi, Snjezana Zaja‐Milatovic, Gina R. Petroni, Paula M. Fracasso, Patrick M. Dillon, Christopher Y. Thomas, Christopher A. Moskaluk, Bethany J. Horton, David Schiff and Ted M. Burns. Their work appears in journals such as Journal of Clinical Oncology, Blood, Current Hematologic Malignancy Reports, Clinical Cancer Research and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.